TrialClinical cancer research : an official journal of the American Association for Cancer Research2009

Phase II trial of tipifarnib plus neoadjuvant doxorubicin-cyclophosphamide in patients with clinical stage IIB-IIIC breast cancer.

Joseph A Sparano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.